Many cancer drugs suffer from severe adverse effects due to acute high exposure and inadequate distribution to tumors. This technology provides a vehicle for the preferred delivery of existing and approved drugs to tumor environments and local release of the active agent, thereby focusing exposure to tissues in need and reducing unwanted side effects.

The Atmospherica process utilizes naturally occurring, photosynthetic, shell-forming micro-algae to sequester CO2 and store it as calcium carbonate, a highly durable mineral that is stable for millions of years. It is a safe and relatively easy process that can be implemented quickly and cost effectively.

We offer a novel tool for antibiotic treatment. Our approach targets a broad spectrum of bacteria but eliminates the risk of evolving resistance by targeting a multitude of pathways.

We’ve developed a low-cost polymer catalyst designed to replace platinum in water splitting, dramatically increasing hydrogen production rates while reducing capital costs — with broad applicability across electrolysis systems.

Surgical Steps has developed a novel VR surgical training platform that integrates real-time cognitive decision modeling with anatomical simulation—a capability not present in current simulators.

We have discovered new class of therapeutics that reduce the rate of cell growth in cancer and vascular lung diseases.

Our data-driven platform integrates high-throughput analytics and AI for next-generation drug discovery. We leverage novel insights into the foundational biologic pathways of neurodegenerative diseases to discover, evaluate, and develop disease-modifying therapeutics for Alzheimer’s disease, frontotemporal dementia (FTD) , amyotrophic lateral sclerosis (ALS), and other degenerative diseases of the nervous system.

Aquaculture is the fastest growing food production sector in the world yet suffers 10% annual losses due to diseases (that’s ~$25 billion lost). Tools for control of these diseases are insufficient or too expensive. Efficacious and inexpensive solutions to address aquaculture disease are an industry priority. Our viral vector platform can be a solution - flexible and customizable to address finfish and crustacean diseases. It can be delivered orally to lower cost and make it more universally applicable to the industry.